WhitTier Trust Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
WhitTier Trust Company's MRNA Position: Q2 2026 in Review
WhitTier Trust Company held its Moderna (MRNA) position steady in Q2 2026 at 61 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.
WhitTier Trust Company first reported a position in MRNA in Q4 2022 and has held it in 11 quarters since. The position peaked at $10.2K in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- WhitTier Trust Company held 61 shares of Moderna worth $4.87K as of Q2 2026.
- WhitTier Trust Company left its Moderna share count unchanged in Q2 2026.
- Moderna made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1175 holding.
- WhitTier Trust Company first reported a position in Moderna in Q4 2022 and has held it in 11 quarters since.
- WhitTier Trust Company's Moderna position peaked at $10.2K in Q4 2022.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.